Molecular profiling means finding the unique genetic and molecular features of a cancer tumor. Instead of only looking at the tumor under a microscope, this method uses advanced technologies that can check thousands of genes and markers all at once. Doctors use this information to learn what causes a specific patient\u2019s cancer and pick treatments that fit those causes.<\/p>\n
One example is Caris Life Sciences. They have one of the biggest databases that mixes molecular and clinical data. This database has over 580,000 patient records and more than 6.5 million tests, covering over 23,000 genes. Using computer analysis, Caris helps predict how patients might respond to treatments, so doctors can make better choices.<\/p>\n
Molecular profiling helps treat many types of cancer, including hard-to-treat ones like ovarian, breast, lung, and colorectal cancer. For example, certain mutations like EGFR in lung cancer or HER2 in breast cancer guide doctors to use special drugs such as erlotinib or trastuzumab. These drugs work by targeting the specific changes in cancer cells.<\/p>\n
Genetic sequencing is an important part of molecular profiling. It helps find mutations and changes in the cancer cells\u2019 DNA. There are two main types:<\/p>\n
Caris Life Sciences uses these methods in products like MI Exome\u2122 and MI Transcriptome\u2122 as part of their Molecular Intelligence\u00ae platform. This helps doctors look at detailed molecular data to decide the best treatments, including immunotherapy, chemotherapy, or targeted drugs.<\/p>\n
BostonGene uses a system that combines gene sequencing with immune system data. Their platform helps match patients to clinical trials and pick treatments by looking at the tumor, its environment, and the patient\u2019s immune response. The AI-based system gives doctors better data for choosing therapies.<\/p>\n
Molecular profiling offers many benefits for doctors and medical staff:<\/p>\n
From an operations view, medical centers need strong IT systems. These systems handle lots of data from sequencing, tissue images, and medical records. Staff also need proper training to add molecular test results into electronic health records and decision tools smoothly.<\/p>\n
<\/p>\n